Intestinal lipoprotein assembly in apobec-1-/- mice reveals subtle alterations in triglyceride secretion coupled with a shift to larger lipoproteins

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 285, Issue 4 48-4, 2003, Pages

  Xie, Yan ^a   Nassir, Fatiha ^a   Luo, Jianyang ^a   Buhman, Kimberly ^a   Davidson, Nicholas O ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apolipoprotein B 100; Apolipoprotein B 48; Chylomicrons; Very low density lipoproteins

Indexed keywords

APOLIPOPROTEIN B100; CHYLOMICRON; LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; INTESTINE ABSORPTION; INTESTINE CELL; INTESTINE MUCOSA; LIPID METABOLISM; LIPOPROTEIN SECRETION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN PROCESSING; RNA EDITING; STRUCTURAL GENE; TRANSCRIPTION REGULATION;

EID: 0141813341     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00202.2003     Document Type: Article

References (37)

1. Anant S and Davidson NO. Molecular mechanisms of apolipoprotein B mRNA editing. Curr Opin Lipidol 12: 159-165, 2001.
2. Bakillah A and Hussain MM. Binding of microsomal triglyceride transfer protein to lipids results in increased affinity for apolipoprotein B: evidence for stable microsomal MTP-lipid complexes. J Biol Chem 276: 31466-31473, 2001.
3. Bakillah A, Nayak N, Saxena U, Medford RM, and Hussain MM. Decreased secretion of ApoB follows inhibition of Apo-BMTP binding by a novel antagonist. Biochemistry 39: 4892-4899, 2000.
4. Basque JR, Levy E, Beaulieu JF, and Menard D. Apolipoproteins in human fetal colon: immunolocalization, biogenesis, and hormonal regulation. J Cell Biochem 70: 354-365, 1998.
5. Baum CL, Teng BB, and Davidson NO. Apolipoprotein B messenger RNA editing in the rat liver. Modulation by fasting and refeeding a high carbohydrate diet. J Biol Chem 265: 19263-19270, 1990.
6. Buhman KK, Smith SJ, Stone SJ, Repa JJ, Wong JS, Knapp FF Jr, Burri BJ, Hamilton RL, Abumrad NA, and Farese RV Jr. DGAT1 is not essential for intestinal triacylglycerol absorption or chylomicron synthesis. J Biol Chem 277: 25474-25479, 2002.
7. Cartwright IJ and Higgins JA. Isolated rabbit enterocytes as a model cell system for investigations of chylomicron assembly and secretion. J Lipid Res 40: 1357-1365, 1999.
8. Cartwright IJ and Higgins JA. Increased dietary triacylglycerol markedly enhances the ability of isolated rabbit enterocytes to secrete chylomicrons: an effect related to dietary fatty acid composition. J Lipid Res 40: 1858-1866, 1999.
9. Cartwright IJ and Higgins JA. Direct evidence for a two-step assembly of ApoB48-containing lipoproteins in the lumen of the smooth endoplasmic reticulum of rabbit enterocytes. J Biol Chem 276: 48048-48057, 2001.
10. Cartwright IJ, Plonne D, and Higgins JA. Intracellular events in the assembly of chylomicrons in rabbit enterocytes. J Lipid Res 41: 1728-1739, 2000.
11. Davidson NO. Intestinal lipid absorption. In: Textbook of Gastroenterology, edited by Yamada T. Philadelphia, PA: Lippincott, William & Wilkins, 1999, p 428-456.
12. Davidson NO and Shelness GS. Apolipoprotein B: mRNA editing, lipoprotein assembly, and presecretory degradation. Annu Rev Nutr 20: 169-193, 2000.
13. Farese RV Jr, Veniant MM, Cham CM, Flynn LM, Pierotti V, Loring JF, Traber M, Ruland S, Stokowski RS, Huszar D, and Young SG. Phenotypic analysis of mice expressing exclusively apolipoprotein B48 or apolipoprotein B100. Proc Natl Acad Sci USA 93: 6393-6398, 1996.
14. Fisher EA and Ginsberg HN. Complexity in the secretory pathway: the assembly and secretion of apolipoprotein B-containing lipoproteins. J Biol Chem 277: 17377-17380, 2002.
15. Giannoni F, Chou SC, Skarosi SF, Verp MS, Field FJ, Coleman RA, and Davidson NO. Developmental regulation of the catalytic subunit of the apolipoprotein B mRNA editing enzyme (APOBEC-1) in human small intestine. J Lipid Res 36: 1664-1675, 1995.
16. Greeve J, Altkemper I, Dieterich JH, Greten H, and Windler E. Apolipoprotein B mRNA editing in 12 different mammalian species: hepatic expression is reflected in low concentrations of apoB-containing plasma lipoproteins. J Lipid Res 34: 1367-1383, 1993.
17. Hirano K, Young SG, Farese RV Jr, Ng J, Sande E, Warburton C, Powell-Braxton LM, and Davidson NO. Targeted disruption of the mouse apobec-1 gene abolishes apolipoprotein B mRNA editing and eliminates apolipoprotein B48. J Biol Chem 271: 9887-9890, 1996.
18. Kendrick JS, Chan L, and Higgins JA. Superior role of apolipoprotein B48 over apolipoprotein B100 in chylomicron assembly and fat absorption: an investigation of apobec-1 knockout and wild-type mice. Biochem J 356: 821-827, 2001.
19. Lau PP, Cahill DJ, Zhu HJ, and Chan L. Ethanol modulates apolipoprotein B mRNA editing in the rat. J Lipid Res 36: 2069-2078, 1995.
20. Levy E, Beaulieu JF, Delvin E, Seidman E, Yotov W, Basque JR, and Menard D. Human crypt intestinal epithelial cells are capable of lipid production, apolipoprotein synthesis, and lipoprotein assembly. J Lipid Res 41: 12-22, 2000.
21. Levy E and Menard D. Developmental aspects of lipid and lipoprotein synthesis and secretion in human gut. Microsc Res Tech 49: 363-373, 2000.
22. Levy E, Yotov W, Seidman EG, Garofalo C, Delvin E, and Menard D. Caco-2 cells and human fetal colon: a comparative analysis of their lipid transport. Biochim Biophys Acta 1439: 353-362, 1999.
23. Liao W and Chan L. Apolipoprotein B, a paradigm for proteins regulated by intracellular degradation, does not undergo intracellular degradation in Caco-2 cells. J Biol Chem 275: 3950-3956, 2000.
24. Lopez-Miranda J, Kam N, Osada J, Rodriguez C, Fernandez P, Contois J, Schaefer EJ, and Ordovas JM. Effect of fat feeding on human intestinal apolipoprotein B mRNA levels and editing. Biochim Biophys Acta 1214: 143-147, 1994.
25. Lu S, Yao Y, Meng S, Cheng X, and Black DD. Overexpression of apolipoprotein A-IV enhances lipid transport in newborn swine intestinal epithelial cells. J Biol Chem 277: 31929-31937, 2002.
26. Morrison JR, Paszty C, Stevens ME, Hughes SD, Forte T, Scott J, and Rubin EM. Apolipoprotein B RNA editing enzyme-deficient mice are viable despite alterations in lipoprotein metabolism. Proc Natl Acad Sci USA 93: 7154-7159, 1996.
27. Nakamuta M, Chang BH, Zsigmond E, Kobayashi K, Lei H, Ishida BY, Oka K, Li E, and Chan L. Complete phenotypic characterization of apobec-1 knockout mice with a wild-type genetic background and a human apolipoprotein B transgenic background, and restoration of apolipoprotein B mRNA editing by somatic gene transfer of Apobec-1. J Biol Chem 271: 25981-25988, 1996.
28. Phung TL, Sowden MP, Sparks JD, Sparks CE, and Smith HC. Regulation of hepatic apolipoprotein B RNA editing in the genetically obese Zucker rat. Metabolism 45: 1056-1058, 1996.
29. Shoulders CC, Brett DJ, Bayliss JD, Narcisi TM, Jarmuz A, Grantham TT, Leoni PR, Bhattacharya S, Pease RJ, Cullen PM, Levi S, Byfield PGH, Purkiss P, and Scott J. Abetalipoproteinemia is caused by defects of the gene encoding the 97 kDa subunit of a microsomal triglyceride transfer protein. Hum Mol Genet 2: 2109-2116, 1993.
30. Stan S, Delvin E, Lambert M, Seidman E, and Levy E. Apo A-IV: an update on regulation and physiologic functions. Biochim Biophys Acta 1631: 177-187, 2003.
31. Teng B, Verp M, Salomon J, and Davidson NO. Apolipoprotein B messenger RNA editing is developmentally regulated and widely expressed in human tissues. J Biol Chem 265: 20616-20620, 1990.
32. Tso P. Intestinal lipid absorption. In: Physiology of the Gastrointestinal Tract, edited by Johnson LR. New York: Raven, 1994, p 1867-1907.
33. Van Mater D, Sowden MP, Cianci J, Sparks JD, Sparks CE, Ballatori N, and Smith HC. Ethanol increases apolipoprotein B mRNA editing in rat primary hepatocytes and McArdle cells. Biochem Biophys Res Commun 252: 334-339, 1998.
34. Wang DQ, Paigen B, and Carey MC. Genetic factors at the enterocyte level account for variations in intestinal cholesterol absorption efficiency among inbred strains of mice. J Lipid Res 42:1820-1830, 2001.
35. Wetterau JR, Aggerbeck LP, Bouma ME, Eisenberg C, Munck A, Hermier M, Schmitz J, Gay G, Rader DJ, and Gregg RE. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science 258: 999-1001, 1992.
36. Young SG. Recent progress in understanding apolipoprotein B. Circulation 82: 1574-1594, 1990.
37. Yue P, Yuan B, Gerhard DS, Neuman RJ, Isley WL, Harris WS, and Schonfeld G. Novel mutations of APOB cause ApoB truncations undetectable in plasma and familial hypobetalipoproteinemia. Hum Mutat 20: 110-116, 2002.